Allosteric Modulation of Protease-Activated Receptor Signaling

Author(s): I. Canto, U. J.K. Soh, J. Trejo.

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 12 , Issue 9 , 2012

Become EABM
Become Reviewer

Abstract:

The protease-activated receptors (PARs) are G protein-coupled receptors (GPCRs) that are uniquely activated by proteolysis. PARs mediate hemostasis, thrombosis, inflammation, embryonic development and progression of certain malignant cancers. The family of PARs include four members: PAR1, PAR2, PAR3 and PAR4. PARs harbor a cryptic ligand sequence within their N-terminus that is exposed following proteolytic cleavage. The newly formed PAR Nterminus functions as a tethered ligand that binds intramolecularly to the receptor to trigger transmembrane signaling. This unique mechanism of activation would indicate that regardless of the activating protease, cleavage of PARs would unmask a tethered ligand sequence that would induce a similar active receptor conformation and signaling response. However, this is not the case. Recent studies demonstrate that PARs can be differentially activated by synthetic peptide agonists, proteases or through dimerization, that ultimately result in distinct cellular responses. In some cases, allosteric modulation of PARs involves compartmentalization in caveolae, plasma membrane microdomains enriched in cholesterol. Here, we discuss some mechanisms that lead to allosteric modulation of PAR signaling.

Keywords: Thrombin, GPCR, G protein, caveolae, palmitoylation, kallikriens, guanine nucleotide, SFLLRN, TFLLRNPNDK, fibroblast-to-myofibroblast

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 12
ISSUE: 9
Year: 2012
Page: [804 - 811]
Pages: 8
DOI: 10.2174/138955712800959116
Price: $58

Article Metrics

PDF: 14